Furthermore, the lncRNA‐MEG3 displayed a notable capacity in prognosticating the risk associated with AIS (AUC = 0.7406, 95% CI: 0.6137–0.8674) and AIS risk in diabetics (AUC = 0.8911, 95% CI: 0.8052–0.9770) (Figure 1D,E). Here, MEG3 is linked to androgen insensitivity syndrome.